Why is Aristo Bio-Tech falling/rising?

As of 30-Sep, Aristo Bio-Tech & Lifescience Ltd's stock price is currently at 132.70, reflecting an increase of 6.5, or 5.15%. The stock has shown a performance today that outperformed its sector by 5.26%. However, it is important to note that the delivery volume has significantly decreased, falling by 68.75% against the 5-day average, indicating a decline in investor participation. In terms of returns, the stock has performed positively over the past month with a gain of 10.03%, while it has seen a slight decline of 0.23% year-to-date. The stock is currently trading above its 20-day, 50-day, 100-day, and 200-day moving averages, although it is below the 5-day moving average.
Broader market context shows that while Aristo Bio-Tech has outperformed the Sensex in the short term, with a 1-week decline of 3.70% compared to the Sensex's 2.22%, it has still managed to achieve a positive return over the past month. The broader market has shown mixed performance, with the Sensex gaining 0.75% over the same period. Despite the stock's recent rise, the significant drop in delivery volume may suggest caution among investors, which could impact future price movements. Overall, while the stock is currently rising, the falling investor participation could pose challenges ahead.